|
|
| | | | | | Dear Colleagues,
| | | | | | | | The topic of the 14th International Symposium on Hodgkin Lymphoma (ISHL14) will be:
“Hodgkin lymphoma 2026: progress through personalisation“. | | | | | |
|
 |
| | | | | | We warmly invite physicians, researchers, and healthcare professionals to save the date for this key event in the field of Hodgkin lymphoma:
| | | | | | | | 📍 Cologne, Germany – Gürzenich Hall Conference Center
📅 October 03–05, 2026 | | | | | | | | | | | | | |
|
| | | | | | ISHL14 will provide:
- Cutting-edge scientific sessions highlighting the latest advances in biology, diagnostics, and therapy of Hodgkin lymphoma
- Clinical updates that are relevant for daily practice, presented by international experts
- Opportunities for abstract submission and presentation of your own research
- An educational session and satellite symposia on other lymphomas
- Interactive discussions and networking with colleagues from around the globe.
| | | | | |
|
|
| | | | | | We look forward to welcoming you in Cologne for an inspiring scientific meeting and to shape the future of personalised Hodgkin lymphoma care together.
| | | | | |
|
| | Best regards,
| | | | | | | | Peter Borchmann, MD,
Symposium Chairman | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
Justin Ferdinandus, MD,
Symposium Co-Chair | |
| | | | |
|
|
|
